Neuland Laboratories Limited (BOM:524558)
17,694
+393 (2.27%)
At close: May 8, 2026
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 227.01 billion as of May 8, 2026. Its market cap has increased by 37.97% in one year.
Market Cap
227.01B
Enterprise Value
227.97B
Revenue
15.75B
Ranking
n/a
PE Ratio
126.72
Stock Price
17,693.65
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 227.01B, an increase of 67,635.23%. That is a compound annual growth rate of 29.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 227.01B | 16.48% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shilpa Medicare | 85.32B |
| Suven Life Sciences | 59.11B |
| Gujarat Themis Biosyn | 43.42B |
| IOL Chemicals and Pharmaceuticals | 28.47B |
| Sai Parenteral's | 21.64B |
| NGL Fine-Chem | 14.50B |
| Bajaj HealthCare | 10.64B |
| Anlon Healthcare | 7.48B |